Press

Ovaio Policistico: un aiuto da fragole e arance

VIVERSANI E BELLI
Settimanale 8 luglio 2016

Interessa il 5-10% delle donne in età riproduttiva e, spesso, rende di difficile avere un figlio. La sindrome dell’ovaio policistico infatti è uno dei motivi più frequenti dell’infertilità.

Al World pediatric and adolescent gynecology congress, il simposio scientifico da poco concluso a Firenze, è stata presentata una sostanza che sembra in …

More
Infertility / Myo-Inositol

Inositol safety clinical evidences

Myo-inositol is a six carbon cyclitol that contains five equatorial and one axial hydroxyl groups. Myo-inositol has been classified as an insulin sensitizing agent and it is commonly used in the treatment of the Polycystic Ovary Syndrome (PCOS). However, despite its wide clinical use, there is still scarce information on the myo-inositol safety …

More
Infertility / PCOS

Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments

 

Polycystic ovary syndrome (PCOS) is one of the most common female endocrine disorder that affects 6–15% of the female population. It is a very complex syndrome that involves the hypothalamus, the pituitary gland, the ovaries, the adrenal gland and the peripheral adipose tissue that together contribute to create a generally imbalance, associated with …

More
Infertility / PCOS

PCOS Features, Diagnostic Criteria and Treatments

Polycystic ovary syndrome (PCOS) is one of the most common female endocrine disorder that affects 6–15% of the female population. It is a very complex syndrome that involves the hypothalamus, the pituitary gland, the ovaries, the adrenal gland and the peripheral adipose tissue that together contribute to create a generally imbalance, associated with …

More
Infertility / PCOS

Polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is one of the most common female endocrine disorder that affects 6–15% of the female population. It is a very complex syndrome that involves the hypothalamus, the pituitary gland, the ovaries, the adrenal gland and the peripheral adipose tissue that together contribute to create a generally imbalance, associated with …

More
Infertility / Myo-Inositol

Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age. It is characterized by chronic anovulation, hyperandrogenism, and insulin resistance. It is the main cause of infertility due to the menstrual dysfunction and metabolic disorders. Women with PCOS also have an increased cardiovascular risk because of dyslipidemia and …

More
Infertility / Myo-Inositol

Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use

Objective: Dose-dependent side effects related to myo-inositol (MI) oral administration represent a significant shortcoming for its clinical use. Aiming to search for a pharmaceutical form able to be better absorbed, the pharmacokinetic (PK) profile of the new manufactured MI soft gelatin capsule form was evaluated and compared with the commercially available MI powder.
Research design and methods: A …

More
Infertility / Myo-Inositol

Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use

 

Objective: Dose-dependent side effects related to myo-inositol (MI) oral administration represent a significant shortcoming for its clinical use. Aiming to search for a pharmaceutical form able to be better absorbed, the pharmacokinetic (PK) profile of the new manufactured MI soft gelatin capsule form was evaluated and compared with the commercially available MI powder.

More

  • 1
  • 2